These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 30576790)
1. Design, development and evaluation of PEGylated rhGH with preserving its bioactivity at highest level after modification. Karbasian M; Kouchakzadeh H; Anamaghi PN; Sefidbakht Y Int J Pharm; 2019 Feb; 557():9-17. PubMed ID: 30576790 [TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics of rhGH decorated by polyethylene glycol in rat in vivo]. Jiang L; Cai YM; Zeng Y; Huang J; Chen ZM Yao Xue Xue Bao; 2009 May; 44(5):506-9. PubMed ID: 19618727 [TBL] [Abstract][Full Text] [Related]
3. The effect of polyethylene glycol recombinant human growth hormone on growth and glucose metabolism in hypophysectomized rats. Zhang ZX; Liu YK; Pan H; Pan L; Zhang Q; Su HM; Zhao QL; Li H; He C Growth Horm IGF Res; 2012 Feb; 22(1):30-5. PubMed ID: 22257554 [TBL] [Abstract][Full Text] [Related]
4. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method. Kang J; Wu F; Cai Y; Xu M; He M; Yuan W Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681 [TBL] [Abstract][Full Text] [Related]
5. Isoform separation and structural identification of mono-PEGylated recombinant human growth hormone (PEG-rhGH) with pH gradient chromatography. Qin X; Li J; Li Y; Gan Y; Huang H; Liang C J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():206-213. PubMed ID: 28153672 [TBL] [Abstract][Full Text] [Related]
6. Precise and combinatorial PEGylation generates a low-immunogenic and stable form of human growth hormone. Wu L; Chen J; Wu Y; Zhang B; Cai X; Zhang Z; Wang Y; Si L; Xu H; Zheng Y; Zhang C; Liang C; Li J; Zhang L; Zhang Q; Zhou D J Control Release; 2017 Mar; 249():84-93. PubMed ID: 28131652 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic/pharmacodynamic (PK/PD) differentiation of native and PEGylated recombinant human growth hormone (rhGH and PEG-rhGH) in the rat model of osteoarthritis. Nemirovskiy O; Zheng YJ; Tung D; Korniski B; Settle S; Skepner A; Yates M; Aggarwal P; Sunyer T; Aguiar DJ Xenobiotica; 2010 Aug; 40(8):586-92. PubMed ID: 20509748 [TBL] [Abstract][Full Text] [Related]
8. A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles. Wei Y; Wang Y; Kang A; Wang W; Ho SV; Gao J; Ma G; Su Z Mol Pharm; 2012 Jul; 9(7):2039-48. PubMed ID: 22663348 [TBL] [Abstract][Full Text] [Related]
9. A long-acting, mono-PEGylated human growth hormone analog is a potent stimulator of weight gain and bone growth in hypophysectomized rats. Cox GN; Rosendahl MS; Chlipala EA; Smith DJ; Carlson SJ; Doherty DH Endocrinology; 2007 Apr; 148(4):1590-7. PubMed ID: 17234711 [TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children. Hou L; Chen ZH; Liu D; Cheng YG; Luo XP Drug Des Devel Ther; 2016; 10():13-21. PubMed ID: 26719670 [TBL] [Abstract][Full Text] [Related]
11. Phenyl amide linker improves the pharmacokinetics and pharmacodynamics of N-terminally mono-PEGylated human growth hormone. Wu L; Ji S; Shen L; Hu T Mol Pharm; 2014 Sep; 11(9):3080-9. PubMed ID: 25115329 [TBL] [Abstract][Full Text] [Related]
12. N-Terminal Modification with Pseudo-Bifunctional PEG-Hexadecane Markedly Improves the Pharmacological Profile of Human Growth Hormone. Wu L; Ji S; Hu T Mol Pharm; 2015 May; 12(5):1402-11. PubMed ID: 25849255 [TBL] [Abstract][Full Text] [Related]
13. [Interferon alpha-2b modified with polyethylene glycol]. Wu Y; Zhai Y; Lei J; Ma G; Su Z Sheng Wu Gong Cheng Xue Bao; 2008 Sep; 24(9):1658-63. PubMed ID: 19160853 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of bioactivity and pharmacokinetic characteristics of PEGylated P.pastoris-expressed erythropoietin. Maleki A; Najafabadi AR; Roohvand F; Shafiee A; Khanahmad H; Faghihi H; Hedayati MH; Tajerzadeh H Drug Deliv; 2011 Nov; 18(8):570-7. PubMed ID: 21892875 [TBL] [Abstract][Full Text] [Related]
15. Investigation of PEG crystallization in frozen and freeze-dried PEGylated recombinant human growth hormone-sucrose systems: implications on storage stability. Bhatnagar BS; Martin SWH; Hodge TS; Das TK; Joseph L; Teagarden DL; Shalaev EY; Suryanarayanan R J Pharm Sci; 2011 Aug; 100(8):3062-3075. PubMed ID: 21491456 [TBL] [Abstract][Full Text] [Related]
16. Long-Acting Human Growth Hormone Receptor Antagonists Produced in Wang Y; Langley RJ; Tamshen K; Jamieson SM; Lu M; Maynard HD; Perry JK Bioconjug Chem; 2020 Jun; 31(6):1651-1660. PubMed ID: 32423203 [TBL] [Abstract][Full Text] [Related]
17. Long-acting PEGylated recombinant human growth hormone (Jintrolong) for children with growth hormone deficiency: phase II and phase III multicenter, randomized studies. Luo X; Hou L; Liang L; Dong G; Shen S; Zhao Z; Gong CX; Li Y; Du ML; Su Z; Du H; Yan C Eur J Endocrinol; 2017 Aug; 177(2):195-205. PubMed ID: 28566441 [TBL] [Abstract][Full Text] [Related]
18. Preparation and in vivo evaluation of PCADK/PLGA microspheres for improving stability and efficacy of rhGH. Wang C; Yu C; Liu J; Teng L; Sun F; Li Y Int J Pharm; 2015 Nov; 495(2):924-31. PubMed ID: 26456269 [TBL] [Abstract][Full Text] [Related]
19. Long-acting interferon-alpha 2a modified with a trimer-structured polyethylene glycol: preparation, in vitro bioactivity, in vivo stability and pharmacokinetics. Jo YW; Youn YS; Lee SH; Kim BM; Kang SH; Yoo M; Choi EC; Lee KC Int J Pharm; 2006 Feb; 309(1-2):87-93. PubMed ID: 16406701 [TBL] [Abstract][Full Text] [Related]
20. Characterization of recombinant human growth hormone variants from sodium hyaluronate-based sustained release formulation of rhGH under heat stress. Kim SJ; Kim CW Anal Biochem; 2015 Sep; 485():59-65. PubMed ID: 26093039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]